Journal ArticleDOI
Apixaban and dalteparin in active malignancy-associated venous thromboembolism: The ADAM VTE trial.
Robert D. McBane,Waldemar E. Wysokinski,Jennifer Le-Rademacher,Tyler Zemla,Aneel A. Ashrani,Alfonso Tafur,Usha Perepu,Daniel M. Anderson,Krishna Gundabolu,Charles Kuzma,Juliana Perez Botero,Roberto A. Leon Ferre,Stanislav Henkin,Charles J. Lenz,Damon E. Houghton,Prakash Vishnu,Charles L. Loprinzi +16 more
TLDR
Low‐molecular‐weight heparin is the guideline‐endorsed treatment for cancer‐associated venous thromboembolism (VTE) and apixaban is approved for the treatment of acute VTE.About:
This article is published in Journal of Thrombosis and Haemostasis.The article was published on 2020-02-01. It has received 326 citations till now. The article focuses on the topics: Apixaban.read more
Citations
More filters
Journal ArticleDOI
2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS).
Alexander R. Lyon,Teresa López-Fernández,Liam Couch,Riccardo Asteggiano,Marianne C Aznar,Jutta Bergler-Klein,Giuseppe Boriani,Daniela Cardinale,Raul Cordoba,Bernard Cosyns,D Cutter,Evandro de Azambuja,W. De Boer,Susan Dent,Dimitrios Farmakis,Sofie Gevaert,D. Gorog,A. Herrmann,Daniel J. Lenihan,Javid Moslehi,Brenda Moura,Sonja S Salinger,R. Stephens,Thomas M. Suter,Sebastian Szmit,Juan Tamargo,Paaladinesh Thavendiranathan,Carlo G. Tocchetti,P. Van Der Meer,Helena J H van der Pal +29 more
Journal ArticleDOI
American Society of Hematology 2021 guidelines for management of venous thromboembolism: prevention and treatment in patients with cancer
Gary H. Lyman,Gary H. Lyman,Marc Carrier,Cihan Ay,Marcello Di Nisio,Lisa K. Hicks,Alok A. Khorana,Andrew D. Leavitt,Agnes Y.Y. Lee,Agnes Y.Y. Lee,Fergus Macbeth,Rebecca L. Morgan,Simon Noble,Elizabeth A. Sexton,David D. Stenehjem,Wojtek Wiercioch,Lara A Kahale,Pablo Alonso-Coello +17 more
TL;DR: In this paper, the authors present evidence-based guidelines of the American Society of Hematology (ASH) to support patients, clinicians, and other health care professionals in their decisions about the prevention and treatment of VTE in patients with cancer.
Journal ArticleDOI
2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS).
Alexander R. Lyon,Teresa López-Fernández,Liam Couch,Riccardo Asteggiano,Marianne C. Aznar,Jutta Bergler-Klein,Giuseppe Boriani,Daniela Cardinale,Raul Cordoba,Bernard Cosyns,D Cutter,Evandro de Azambuja,W. De Boer,Susan Dent,Dimitrios Farmakis,Sofie Gevaert,Diana A. Gorog,A. Herrmann,Daniel J. Lenihan,Javid Moslehi,Brenda Moura,Sonja S Salinger,R. Stephens,Thomas M. Suter,Sebastian Szmit,Juan Tamargo,Paaladinesh Thavendiranathan,Carlo G. Tocchetti,P. Van Der Meer,Helena J H van der Pal +29 more
Journal ArticleDOI
Editor's Choice - European Society for Vascular Surgery (ESVS) 2021 Clinical Practice Guidelines on the Management of Venous Thrombosis.
Stavros K. Kakkos,Manjit Gohel,Niels Bækgaard,Rupert Bauersachs,Sergi Bellmunt-Montoya,Stephen A. Black,Stephen A. Black,Arina J. ten Cate-Hoek,Ismail Elalamy,Florian K. Enzmann,George Geroulakos,Anders Gottsäter,Beverley J. Hunt,Armando Mansilha,Andrew N. Nicolaides,Andrew N. Nicolaides,Per Morten Sandset,Gerard Stansby,Gerard Stansby,Gert J. de Borst,Frederico Bastos Gonçalves,Nabil Chakfe,Robert J. Hinchliffe,Philippe Kolh,Igor Koncar,Jes S. Lindholt,Riikka Tulamo,Christopher P. Twine,Frank Vermassen,Anders Wanhainen,Marianne G. De Maeseneer,Anthony J. Comerota,Peter Gloviczki,Marieke J. H. A. Kruip,Manuel Monreal,Paolo Prandoni,Melina Vega de Ceniga +36 more
TL;DR: The European Society for Vascular Surgery (ESVS) 2021 Clinical Practice Guidelines on the Management of Venous Thrombosis as discussed by the authors have been published for the management of venous thrombotic vessels.
Journal ArticleDOI
Direct Oral Anticoagulant Use: A Practical Guide to Common Clinical Challenges.
TL;DR: This review will provide an overview of DOACs and act as a practical reference for clinicians to optimize DOAC use among common challenging scenarios and Topics addressed include appropriate indications, use in patients with specific comorbidities, and cost considerations.
References
More filters
Journal ArticleDOI
Apixaban versus Warfarin in Patients with Atrial Fibrillation
Christopher B. Granger,John H. Alexander,Renato D. Lopes,Elaine M. Hylek,Michael G. Hanna,Hussein R. Al-Khalidi,Jack Ansell,Dan Atar,Alvaro Avezum,M. Cecilia Bahit,Rafael Diaz,J. Donald Easton,Justin A. Ezekowitz,Greg C. Flaker,David A. Garcia,Margarida Geraldes,Bernard J. Gersh,Sergey P. Golitsyn,Shinya Goto,Antonio G. Hermosillo,Stefan H. Hohnloser,John D. Horowitz,Puneet Mohan,Petr Jansky,Basil S. Lewis,Jose Lopez-Sendon,Prem Pais,Alexander Parkhomenko,Jun Zhu,Lars Wallentin +29 more
TL;DR: In patients with atrial fibrillation, apixaban was superior to warfarin in preventing stroke or systemic embolism, caused less bleeding, and resulted in lower mortality.
Journal ArticleDOI
Definition of major bleeding in clinical investigations of antihemostatic medicinal products in surgical patients.
Sam Schulman,U. Angerås,David Bergqvist,Bengt I. Eriksson,Michael R. Lassen,William D. Fisher +5 more
TL;DR: A definition of major bleeding that should be applicable to all agents that interfere with hemostasis is developed and is to seek approval from the regulatory authorities to enhance its incorporation into future clinical trial protocols.
Journal ArticleDOI
Low-Molecular-Weight Heparin versus a Coumarin for the Prevention of Recurrent Venous Thromboembolism in Patients with Cancer
Agnes Y.Y. Lee,Mark Levine,Ross I. Baker,Chris Bowden,Ajay K. Kakkar,Martin H. Prins,Frederick R. Rickles,Jim A. Julian,Susan Haley,Michael J. Kovacs,Michael Gent +10 more
TL;DR: In patients with cancer and acute venous thromboembolism, dalteparin was more effective than an oral anticoagulant in reducing the risk of recurrent thrombosis without increasing therisk of bleeding.
Journal ArticleDOI
Apixaban in Patients with Atrial Fibrillation
Stuart J. Connolly,John W. Eikelboom,Campbell D. Joyner,Hans-Christoph Diener,Robert G. Hart,Sergey P. Golitsyn,Greg C. Flaker,Alvaro Avezum,Stefan H. Hohnloser,Rafael Diaz,Mario Talajic,Jun Zhu,Prem Pais,Andrzej Budaj,Alexander Parkhomenko,Petr Jansky,Patrick J. Commerford,Ru San Tan,Kui-Hian Sim,Basil S. Lewis,Walter Van Mieghem,Jae Hyung Kim,Fernando Lanas-Zanetti,Antonio Gonzalez-Hermosillo,Antonio L. Dans,Muhammad Munawar,John H. Lawrence,Gayle Lewis,Rizwan Afzal,Salim Yusuf +29 more
TL;DR: In patients with atrial fibrillation for whom vitamin K antagonist therapy was unsuitable, apixaban reduced the risk of stroke or systemic embolism without significantly increasing therisk of major bleeding or intracranial hemorrhage.
Journal ArticleDOI
Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case-control study.
John A. Heit,Marc D. Silverstein,Marc D. Silverstein,David N. Mohr,Tanya M. Petterson,W. Michael O'Fallon,L. Joseph Melton +6 more
TL;DR: Hospital or nursing home confinement, surgery, trauma, malignant neoplasm, chemotherapy, neurologic disease with paresis, central venous catheter or pacemaker, varicose veins, and superficial vein thrombosis are independent and important risk factors for VTE.
Related Papers (5)
Edoxaban for the Treatment of Cancer-Associated Venous Thromboembolism
2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European respiratory society (ERS)
Stavros Konstantinides,Guy Meyer,Cecilia Becattini,Héctor Bueno,Geert-Jan Geersing,Veli-Pekka Harjola,Menno V. Huisman,Marc Humbert,Catriona Jennings,David Jiménez,Nils Kucher,Irene M. Lang,Mareike Lankeit,Roberto Lorusso,Lucia Mazzolai,Nicolas Meneveau,Fionnuala Ní Áinle,Paolo Prandoni,Piotr Pruszczyk,Marc Philip Righini,Adam Torbicki,Eric Van Belle,José Luis Zamorano +22 more